Synlogic Stock Forecast, Price & News

Synlogic (NASDAQ:SYBX) Frequently Asked Questions

Is Synlogic a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Synlogic in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Synlogic stock.
View analyst ratings for Synlogic or view top-rated stocks.

How has Synlogic's stock price been impacted by Coronavirus (COVID-19)?

Synlogic's stock was trading at $1.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SYBX shares have increased by 7.1% and is now trading at $1.65.
View which stocks have been most impacted by COVID-19.

When is Synlogic's next earnings date?

Synlogic is scheduled to release its next quarterly earnings announcement on Thursday, March 24th 2022.
View our earnings forecast for Synlogic.

How were Synlogic's earnings last quarter?

Synlogic, Inc. (NASDAQ:SYBX) issued its quarterly earnings data on Wednesday, November, 10th. The biotechnology company reported ($0.29) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.29). The biotechnology company earned $0.92 million during the quarter, compared to analysts' expectations of $0.28 million. During the same quarter in the prior year, the business earned ($0.36) earnings per share.
View Synlogic's earnings history.

When did Synlogic's stock split? How did Synlogic's stock split work?

Shares of Synlogic reverse split on the morning of Monday, August 28th 2017. The 1-7 reverse split was announced on Friday, August 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 25th 2017. An investor that had 100 shares of Synlogic stock prior to the reverse split would have 14 shares after the split.

What price target have analysts set for SYBX?

6 equities research analysts have issued 12 month target prices for Synlogic's shares. Their forecasts range from $7.00 to $15.00. On average, they expect Synlogic's stock price to reach $9.83 in the next twelve months. This suggests a possible upside of 496.0% from the stock's current price.
View analysts' price targets for Synlogic or view top-rated stocks among Wall Street analysts.

Who are Synlogic's key executives?

Synlogic's management team includes the following people:

• Aoife M. Brennan, President, Chief Executive Officer & Director
• Antoine Awad, Chief Operating Officer
• Gregg D. Beloff, Chief Financial Officer
• David L. Hava, Chief Scientific Officer
• Amanda Kay, Senior VP, Head-Business Development & Strategy

Who are some of Synlogic's key competitors?

Some companies that are related to Synlogic include Intercept Pharmaceuticals (ICPT), LumiraDx (LMDX), VBI Vaccines (VBIV), Y-mAbs Therapeutics (YMAB), Tricida (TCDA), Basilea Pharmaceutica (BPMUF), BELLUS Health (BLU), OrganiGram (OGI), ORIC Pharmaceuticals (ORIC), Ocular Therapeutix (OCUL), Prelude Therapeutics (PRLD), DiaMedica Therapeutics (DMCAF), Rigel Pharmaceuticals (RIGL), CytoDyn (CYDY) and PyroGenesis Canada (PYR).
View all of SYBX's competitors.

What other stocks do shareholders of Synlogic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synlogic investors own include Reata Pharmaceuticals (RETA), Approach Resources (AREX), Precision Drilling (PDS), First Financial Bankshares (FFIN), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Corbus Pharmaceuticals (CRBP), Inovio Pharmaceuticals (INO), Rigel Pharmaceuticals (RIGL) and Verastem (VSTM).

What is Synlogic's stock symbol?

Synlogic trades on the NASDAQ under the ticker symbol "SYBX."

How do I buy shares of Synlogic?

Shares of SYBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Synlogic's stock price today?

One share of SYBX stock can currently be purchased for approximately $1.65.

How much money does Synlogic make?

Synlogic has a market capitalization of $115.02 million and generates $550 thousand in revenue each year. The biotechnology company earns $-59.17 million in net income (profit) each year or ($1.32) on an earnings per share basis.

How many employees does Synlogic have?

Synlogic employs 72 workers across the globe.

What is Synlogic's official website?

The official website for Synlogic is www.synlogictx.com.

Where are Synlogic's headquarters?

Synlogic is headquartered at 301 Binney St. Suite 402, Cambridge MA, 02142.

How can I contact Synlogic?

Synlogic's mailing address is 301 Binney St. Suite 402, Cambridge MA, 02142. The biotechnology company can be reached via phone at (617) 401-9975, via email at [email protected], or via fax at 512-681-5201.